1. Home
  2. EMO vs AUTL Comparison

EMO vs AUTL Comparison

Compare EMO & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMO
  • AUTL
  • Stock Information
  • Founded
  • EMO 2011
  • AUTL 2014
  • Country
  • EMO United States
  • AUTL United Kingdom
  • Employees
  • EMO N/A
  • AUTL N/A
  • Industry
  • EMO Investment Managers
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EMO Finance
  • AUTL Health Care
  • Exchange
  • EMO Nasdaq
  • AUTL Nasdaq
  • Market Cap
  • EMO 599.1M
  • AUTL 609.4M
  • IPO Year
  • EMO N/A
  • AUTL 2018
  • Fundamental
  • Price
  • EMO $50.42
  • AUTL $2.22
  • Analyst Decision
  • EMO
  • AUTL Strong Buy
  • Analyst Count
  • EMO 0
  • AUTL 3
  • Target Price
  • EMO N/A
  • AUTL $10.20
  • AVG Volume (30 Days)
  • EMO 27.1K
  • AUTL 1.4M
  • Earning Date
  • EMO 01-01-0001
  • AUTL 03-13-2025
  • Dividend Yield
  • EMO 6.70%
  • AUTL N/A
  • EPS Growth
  • EMO N/A
  • AUTL N/A
  • EPS
  • EMO N/A
  • AUTL N/A
  • Revenue
  • EMO N/A
  • AUTL $10,091,000.00
  • Revenue This Year
  • EMO N/A
  • AUTL $851.83
  • Revenue Next Year
  • EMO N/A
  • AUTL $264.18
  • P/E Ratio
  • EMO N/A
  • AUTL N/A
  • Revenue Growth
  • EMO N/A
  • AUTL 82.71
  • 52 Week Low
  • EMO $26.42
  • AUTL $2.07
  • 52 Week High
  • EMO $40.17
  • AUTL $7.37
  • Technical
  • Relative Strength Index (RSI)
  • EMO 73.13
  • AUTL 38.18
  • Support Level
  • EMO $49.02
  • AUTL $2.18
  • Resistance Level
  • EMO $47.92
  • AUTL $2.38
  • Average True Range (ATR)
  • EMO 0.94
  • AUTL 0.16
  • MACD
  • EMO 0.48
  • AUTL 0.01
  • Stochastic Oscillator
  • EMO 94.34
  • AUTL 7.94

About EMO ClearBridge Energy Midstream Opportunity Fund Inc.

ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: